ABOUT THE CONGRESS
The Global Endocrine Systems & Metabolic Health Congress 2026 (GESMHC 2026) is an international academic forum dedicated to advancing integrated approaches across endocrinology, metabolic disorders, and systemic health regulation.
Endocrine diseases — including diabetes, thyroid disorders, obesity, adrenal dysfunction, reproductive hormonal imbalance, and cardiometabolic syndromes — represent a growing global burden. Yet care delivery, prevention strategies, research translation, and policy coordination remain structurally fragmented.
GESMHC 2026 positions endocrine health within a broader systems-oriented framework that aligns:
• Clinical endocrinology and specialty care pathways
• Metabolic disease prevention and population strategy
• Translational research and implementation science
• Digital diagnostics and AI-enabled decision support
• Workforce sustainability and interdisciplinary collaboration
• Governance, financing, and health system integration
Organized under the WebiConX Global Congress Platform, the congress fosters evidence-driven dialogue connecting clinicians, researchers, policy leaders, and institutional stakeholders working toward scalable endocrine care models.
For detailed thematic domains, refer to the Scientific Program Architecture.
For registration guidance, abstract submission assistance, or participation queries, our support team is available to assist you throughout the congress process.
We ensure a smooth and responsive support experience for all participants.
SCIENTIFIC PROGRAM ARCHITECTURE
The scientific program is structured across six Core Thematic Tracks, each designed to bridge clinical excellence with systemic integration.
Track 1: Clinical Endocrinology & Hormonal Disorders
Description:
Focuses on diagnostic precision, therapeutic advancements, and multidisciplinary management of endocrine conditions.
Subtracks:
• Diabetes & Glycemic Management Innovations
• Thyroid & Parathyroid Disorders
• Adrenal & Pituitary Pathophysiology
• Reproductive & Gonadal Endocrinology
• Pediatric & Developmental Endocrine Disorders
Track 2: Metabolic Health & Cardiometabolic Integration
Description:
Explores obesity, lipid metabolism, insulin resistance, and the intersection between endocrine and cardiovascular systems.
Subtracks:
• Obesity Medicine & Weight Regulation
• Lipid Disorders & Metabolic Syndrome
• Insulin Resistance & Pre-Diabetes Prevention
• Endocrine–Cardiovascular Interactions
• Nutrition, Lifestyle & Metabolic Modulation
Track 3: Translational Endocrine Research & Precision Medicine
Description:
Examines molecular pathways, biomarker discovery, genomics, and translational pipelines in endocrine science.
Subtracks:
• Endocrine Genetics & Epigenetics
• Biomarkers & Diagnostic Innovation
• Precision Medicine in Hormonal Disorders
• Clinical Trials & Therapeutic Development
• Research-to-Practice Implementation Models
Track 4: Endocrine Systems, Policy & Population Health
Description:
Addresses endocrine disease burden at systems and population levels.
Subtracks:
• Diabetes Prevention Programs & Public Health Strategy
• Global Endocrine Disease Epidemiology
• Health Financing & Access Models
• Regulatory & Governance Frameworks
• Health Systems Integration & Care Coordination
Track 5: Digital Endocrinology & AI in Metabolic Care
Description:
Explores digital diagnostics, wearable technologies, AI-driven risk stratification, and data governance.
Subtracks:
• Continuous Glucose Monitoring & Smart Devices
• AI-Based Risk Prediction Models
• Tele-Endocrinology & Remote Care
• Digital Therapeutics & Behavioral Platforms
• Data Governance & Ethical Innovation
Track 6: Workforce, Education & Clinical Leadership
Description:
Focuses on training, interdisciplinary collaboration, and endocrine workforce sustainability.
Subtracks:
• Endocrine Education & Curriculum Reform
• Interdisciplinary Care Teams
• Workforce Distribution & Access Equity
• Leadership in Specialty Care Systems
• Burnout Prevention & Professional Sustainability
For confirmed faculty and leadership, visit the Speakers page.
Confirmed contributors and domain experts can be explored within the Speakers section.
GESMHC 2026 convenes:
• Endocrinologists & Diabetologists
• Internal Medicine Physicians
• Cardiometabolic Specialists
• Clinical Researchers & Scientists
• Public Health Experts
• Policy Advisors
• Digital Health Innovators
• Academic Faculty & Trainees
• Healthcare Administrators
Explore the detailed Agenda for session-level participation opportunities.
GESMHC 2026 responds to growing fragmentation between clinical endocrinology, metabolic prevention systems, financing models, and digital innovation.
By aligning scientific discovery with implementation strategy, governance reform, and interdisciplinary care integration, the congress supports scalable endocrine health system advancement.
Institutions interested in structured collaboration may review Institutional Partnerships.
